April 7th, 2020
Ensuring access to lifesaving technologies during the pandemic
Harvard, MIT, and Stanford commit to COVID-19 technology licensing principles, maximizing access to university innovations
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Licensing
June 17th, 2019
Harvard chemists’ breakthrough in synthesis advances a potent anti-cancer agent
‘Unprecedented achievement’ provides sufficient quantities of a fully synthetic halichondrin molecule for clinical trials now underway
March 20th, 2018
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
August 8th, 2017
Harvard’s Wyss Institute launches Root Robotics, an educational startup to get anyone coding
New company will commercialize Root, an interactive robot that introduces coding to children and provides a path for continuous engagement to career-based coding languages
November 16th, 2016
Tackling blood diseases and immune disorders
Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment
